Covidien Announces European Commercial Launch Of Nellcor Respiration Rate System

(RTTNews) - Healthcare products company Covidien plc. (COV) announced the European commercial launch of its Nellcor Respiration Rate System. In addition to the Adult Respiratory Sensor, the system includes the Nellcor Respiration Rate Version 2.0 software and Nellcor Bedside Respiratory Patient Monitoring System, PM1000N, both of which recently received CE Mark approval.

With this addition to the Nellcor Respiratory Function portfolio - a single-sensor, pleth-based respiration rate monitoring technology - clinicians now can monitor a patient's SpO2, pulse rate and respiration rate through a single integrated finger sensor, the company said.

Respiration rate is a critical vital sign that can act as an early indicator of respiratory complications.

The company stated that the Nellcor Respiration Rate System provides this critical information through a continuous, non-invasive patient monitoring platform that enables clinicians to review respiratory trend data over the course of a patient's treatment. The system is accurate - reporting respiration rates of ± 1 breath per minute when compared to respiration rate derived from a capnography-based reference - easy to use, and may enable earlier intervention in the case of respiratory compromise.